Bibliographic Details
| Title: |
Acknowledgement to Referees. |
| Source: |
CNS Drugs. Dec2024, Vol. 38 Issue 12, p943-947. 5p. |
| Subject Terms: |
*TARDIVE dyskinesia, *SEIZURES (Medicine), *ACADEMIC medical centers, *ISCHEMIC stroke, *HUNTINGTON disease, *PRASUGREL, *BENZODIAZEPINES, *MONOCLONAL antibodies |
| Abstract: |
The document is an acknowledgment to the referees of CNS Drugs for their contributions to the journal in 2024. It highlights the achievements of the journal, including its high Impact Factor and CiteScore. The document lists the members of the Honorary Editorial Board and peer reviewers who have played a crucial role in maintaining the journal's quality standards. It also mentions the most popular articles and their impact, as well as the use of Altmetric system to measure the reach of articles. The Editor expresses gratitude to all contributors and looks forward to sharing more scientific advances in pharmacotherapy for neurological and psychiatric disorders in 2025. [Extracted from the article] |
|
Copyright of CNS Drugs is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
